WA People
BILL · 2025–26 SESSION · LATEST VERSION ESHB 2196

HB 2196: PANDAS, pediatric treatment

Expanding access to PANDA PANS treatment.

Summary

  • Requires private fully insured group health plans to provide coverage for the prophylaxis, diagnosis, and treatment of pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS) and pediatric acute-onset neuropsychiatric syndrome (PANS), including antibiotics, medication and psychological and behavioral therapies to manage neuropsychiatric symptoms, immunomodulating medicines, plasma exchange, and intravenous immunoglobulin therapy (if certain conditions are met).

From the Engrossed Substitute House Bill Report (ESHB 2196), written by the Legislature's nonpartisan staff. Read the full report ↗

Did not pass Did not pass · passed House, stalled in Senate
  1. IntroducedJan 12, 2026
  2. Out of committeeFeb 4, 2026
  3. Passed HouseFeb 16, 2026
  4. Passed Senatestopped here
  5. Governor
  6. Law
Prime sponsor
Tarra Simmons (D-23)
Introduced
January 12, 2026 in the House
Last action
March 12, 2026
Budget
Has a fiscal note
Versions
HB 2196, SHB 2196, ESHB 2196

AN ACT Relating to expanding access to treatment of pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections and pediatric acute-onset neuropsychiatric syndrome;

Sponsors

Prime sponsor: Tarra Simmons (D-23)

10 co-sponsors (7 Democrats, 3 Republicans)

Sam Low R-39Mari Leavitt D-28Dave Paul D-10Greg Nance D-23Davina Duerr D-1Monica Jurado Stonier D-49Travis Couture R-35Lauren Davis D-32David Stuebe R-17Debra Lekanoff D-40

Votes

House · 3rd Reading & Final Passage

Passed February 16, 2026
Version voted on: ESHB 2196
83 Yea 13 Nay 0 Absent 2 Excused
PartyYeaNayAbsentExcused
Democrat58001
Republican251301
How each member voted

Yea (83)

Excused (2)

Permalink to this vote

History

  1. By resolution, returned to House Rules Committee for third reading. (ESHB 2196)
  2. First reading, referred to Health & Long-Term Care. (ESHB 2196)
  3. Third reading, passed; yeas, 83; nays, 13; absent, 0; excused, 2. (ESHB 2196)
  4. Rules suspended. Placed on Third Reading. (ESHB 2196)
  5. Floor amendment(s) adopted. (ESHB 2196)
  6. 1st substitute bill substituted. (ESHB 2196)
  7. 1st substitute bill substituted.
  8. Rules Committee relieved of further consideration. Placed on second reading. (ESHB 2196)
  9. Rules Committee relieved of further consideration. Placed on second reading.
  10. Referred to Rules 2 Review. (ESHB 2196)
  11. Referred to Rules 2 Review.
  12. HCW - Majority; 1st substitute bill be substituted, do pass. (ESHB 2196)
  13. Minority; do not pass. (ESHB 2196)
  14. Minority; without recommendation. (ESHB 2196)
  15. Minority; without recommendation.
  16. Minority; do not pass.
  17. HCW - Majority; 1st substitute bill be substituted, do pass.
  18. HCW - Executive action taken by committee.
  19. First reading, referred to Health Care & Wellness.
  20. Prefiled for introduction.

HB 2196 in other sessions

Bill numbers restart every two years, so the same number is a different bill in each session.

Report wrong or missing information on this page